Alloplex Biotherapeutics is a company that specializes in the development of cellular therapies. It provides SUPLEXA cells, a peripheral blood mononuclear cell (PBMC)-derived multicellular adoptive immunotherapy. The company also explores the higher order combinatorial space of immunomodulators to develop an anti-tumor vaccine.